Trial Profile
A phase I trial to investigate the safety, tolerance and pharmacokinetics of NN9928 in patients with diabetes
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Mar 2015
Price :
$35
*
At a glance
- Drugs NN 9928 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics
- 06 Mar 2015 New trial record